Jose Arjona-Medina @arjonamedina.bsky.social · 01/03/2025I still uncertain about the RL aspect in DeepSeek. To me it looks like a clever way of applaying a PPO-like clipping within a supervised framework, constrained by a fixed reference model. Althought some parts in its formulation are very similar to PPO, I wouldn't describe it as RL. (1/5)🧵 120
Jose Arjona-Medina @arjonamedina.bsky.social · 10/01/2025Any recommendation for a drug discovery related confernece in Europe this year? Im all ears 😄 020
Jose Arjona-Medina @arjonamedina.bsky.social · 29/12/2024Why your transformer-based net does not generalized from small molecules to peptides? Well, here one of the reasons: arxiv.org/abs/2410.01104 Once you know the root of the problem, you can find nice solutions 😉 In our case, a very simple regularization term did the job.arxiv.orgsoftmax is not enough (for sharp out-of-distribution)A key property of reasoning systems is the ability to make sharp decisions on their input data. For contemporary AI systems, a key carrier of sharp behaviour is the softmax function, with its capabili... 1164
Reposted by Jose Arjona-MedinaWillie Neiswanger @willieneis.bsky.social · 10/11/2024I'm making a list of AI for Science researchers on bluesky — let me know if I missed you / if you'd like to join! go.bsky.app/AcP9Lix 16225389
Reposted by Jose Arjona-MedinaCaitlin Mellor @caitlinmellor.bsky.social · 15/11/2024A starter pack for anyone interested in AI & drug discovery :) go.bsky.app/AgYHc8j 295315
Reposted by Jose Arjona-MedinaBen Blaiszik @benblaiszik.bsky.social · 15/11/2024 Follow leading researchers, practitioners, and thought leaders exploring the intersection of #AI, machine learning, data science, and scientific research. 🦋 ➕We are just getting started, please send me others who should be added go.bsky.app/JeFdryY #ML 4310441